Duncan P. Taylor

3.1k total citations · 1 hit paper
44 papers, 2.6k citations indexed

About

Duncan P. Taylor is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Duncan P. Taylor has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Duncan P. Taylor's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Pharmacological Receptor Mechanisms and Effects (12 papers) and Receptor Mechanisms and Signaling (12 papers). Duncan P. Taylor is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Pharmacological Receptor Mechanisms and Effects (12 papers) and Receptor Mechanisms and Signaling (12 papers). Duncan P. Taylor collaborates with scholars based in United States, Germany and Japan. Duncan P. Taylor's co-authors include L.A. Riblet, Michael S. Eison, Candace B. Pert, H.C. Stanton, JoséM. Musacchio, Yossef Itzhak, J.L. Junien, Wayne D. Bowen, Rémi Quirion and S. William Tam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and The FASEB Journal.

In The Last Decade

Duncan P. Taylor

44 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A proposal for the classification of sigma binding sites

1992 689 citations Rémi Quirion, Wayne D. Bowen et al. Trends in Pharmacological Sciences profile →

Peers

Countries citing papers authored by Duncan P. Taylor

Since Specialization

Citations

This map shows the geographic impact of Duncan P. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan P. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan P. Taylor more than expected).

Fields of papers citing papers by Duncan P. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan P. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan P. Taylor. The network helps show where Duncan P. Taylor may publish in the future.

Co-authorship network of co-authors of Duncan P. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan P. Taylor. A scholar is included among the top collaborators of Duncan P. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan P. Taylor. Duncan P. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia 1994 ·Neuropsychopharmacology ·(unknown), Jack M. Gorman, Jan Volavka, (unknown), (unknown), Duncan P. Taylor, Richard L. Borison	49
2	Synthesis and biological characterization of .alpha.-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogs as potential atypical antipsychotic agents 1992 ·Journal of Medicinal Chemistry ·Joseph P. Yevich, James S. New, (unknown), (unknown), (unknown), Duncan P. Taylor, Frank D. Yocca, Michael S. Eison, Davis L. Temple	26
3	A proposal for the classification of sigma binding sites breakdown → 1992 ·Trends in Pharmacological Sciences ·Rémi Quirion, Wayne D. Bowen, Yossef Itzhak, J.L. Junien, JoséM. Musacchio, Richard B. Rothman, (unknown), S. William Tam, Duncan P. Taylor	689
4	Buspirone and related compounds as alternative anxiolytics 1991 ·Neuropeptides ·Duncan P. Taylor, Sandra L. Moon	40
5	Phase I trials of BMY 14802, a potential antipsychotic with affinity for sigma binding sites 1991 ·Schizophrenia Research ·Duncan P. Taylor, Umesh Shukla, Seth A. Wolfe, (unknown), Robert E. Pyke, Errol B. DeSouza	2
6	Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment 1991 ·Life Sciences ·Frank D. Yocca, Arlene S. Eison, Deborah K. Hyslop, Elaine Ryan, Duncan P. Taylor, Gerald Gianutsos	22
7	Serotonin Agents in Anxiety 1990 ·Annals of the New York Academy of Sciences ·Duncan P. Taylor	60
8	H1 antihistamines interact with central sigma receptors 1990 ·Life Sciences ·Nancy M. Gray, Patricia C. Contreras, (unknown), Duncan P. Taylor	18
9	Phencyclidine acts as an N‐methyl‐D‐Aspartate agonist in vitro 1989 ·Drug Development Research ·Duncan P. Taylor, (unknown)	1
10	Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives 1988 ·Journal of Medicinal Chemistry ·James S. New, Joseph P. Yevich, Davis L. Temple, (unknown), (unknown), R. Francis Schlemmer, Michael S. Eison, Duncan P. Taylor, L.A. Riblet	17
11	Buspirone and gepirone: partial agonists at the 5HT/sub 1/A receptor linked to adenylate cyclase (AC) in rat and guinea pig hippocampal preparations 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·Frank D. Yocca, Deborah K. Hyslop, Duncan P. Taylor, Saul Maayani	6
12	Buspirone analogs. 2. Structure-activity relationships of aromatic imide derivatives 1986 ·Journal of Medicinal Chemistry ·James S. New, Joseph P. Yevich, Michael S. Eison, Duncan P. Taylor, Arlene S. Eison, L.A. Riblet, Cam P. VanderMaelen, Davis L. Temple	21
13	Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. 1985 ·Proceedings of the National Academy of Sciences ·Julia A. MacLaughlin, (unknown), Duncan P. Taylor, Elizabeth F. Smith, Michael F. Holick	113
14	Changing concepts of the biochemical action of the anxioselective drug, buspirone 1984 ·Drug Development Research ·Duncan P. Taylor, (unknown), (unknown), Margaret E. Crane, Deborah K. Hyslop, L.A. Riblet	60
15	[3H]tetrahydrotrazodone binding. Association with serotonin binding sites. 1983 ·Molecular Pharmacology ·Dave Kendal, Duncan P. Taylor, S.J. Enna	8
16	Effects of guanine nucleotides on cns neuropeptide receptors 1981 ·PubMed ·Terry W. Moody, Duncan P. Taylor, Candace B. Pert	23
17	Trazodone, a new nontricyclic antidepressant without anticholinergic activity 1980 ·Biochemical Pharmacology ·Duncan P. Taylor, Deborah K. Hyslop, L.A. Riblet	21
18	Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Duncan P. Taylor, B. T. HO	122
19	Characteristics of the adenyl cyclase of the central nervous system of Manduca sexta 1978 ·Comparative Biochemistry and Physiology Part C Comparative Pharmacology ·Duncan P. Taylor, R.W. Newburgh	10
20	Cyclic nucleotides in neuronal and glialenriched fractions from the nerve cord of Manduca sexta 1976 ·Journal of Insect Physiology ·Duncan P. Taylor, (unknown), R.W. Newburgh	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact